The latest trading day saw Veeva Systems (VEEV) settling at $242.75, representing a +1.85% change from its previous close.

Gossamer Bio (GOSS) delivered earnings and revenue surprises of -100.00% and +171.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Veeva Systems (VEEV) reached $241.51 at the closing of the latest trading day, reflecting a +2.08% change compared to its last close.

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -42.86% and +9.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Based on the average brokerage recommendation (ABR), Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

In the closing of the recent trading day, Veeva Systems (VEEV) stood at $217.8, denoting a +2.01% move from the preceding trading day.

The latest trading day saw Veeva Systems (VEEV) settling at $201.56, representing a -3.05% change from its previous close.

In the closing of the recent trading day, Veeva Systems (VEEV) stood at $179.58, denoting a -2.69% move from the preceding trading day.

According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.